ROCKVILLE, Md., May 8, 2008-The FDA today posted on its website a
warning letter sent to Novartis Pharmaceuticals regarding
promotional materials for Trileptal. The letter and
promotional materials are attached.
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment.
Data sources include Micromedex™ (updated May 16th, 2013), Cerner Multum™ (updated May 20th, 2013), Wolters Kluwer™ (updated Apr 30th, 2013) and others. To view content sources and attributions, refer to our editorial policy.